Sponsor study identifier
observational
64
1 country
1
Study Start
March 1, 2023
Actual (reported)Primary Completion
January 31, 2024
Actual (reported)Study Completion
May 31, 2024
Actual (reported)The goal of this observational study is to investigate the correlation between handgrip strength and small airway disease among patients with chronic obstructive pulmonary disease (COPD). The main question it aims to answer is: • Is handgrip strength correlated with small airway disease in COPD patients? Participants will perform handgrip strength test and impulse oscillometry (IOS).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 31, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1, 2023
Actual (reported)January 12, 2024
Actual (reported)January 25, 2024
Actual (reported)January 31, 2024
Actual (reported)May 31, 2024
Actual (reported)Correlation between handgrip strength and small airway disease in COPD patients
This correlation will be reported as correlation coefficient (R).
At day 1 of the study
The best cutoff value of handgrip strength for predicting small airway disease in COPD patients
At day1 of the study
COPD patients aged 40 years or older with a post-bronchodilator ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) \<0.7.
Handgrip strength will be measured by 3 efforts.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
COPD patients aged 40 years or older who are confirmed diagnosis by spirometry (post-bronchodilator FEV1/FVC \<0.7) and smoking history 10 pack-years or more.
Thammasat University Faculty of Medicine
Pathum Thani, Changwat Pathum Thani, 12120, Thailand
Keawon T, Saiphoklang N. Association between handgrip strength and small airway disease in patients with stable chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241281675. doi: 10.1177/17534666241281675.
Narongkorn Saiphoklang, MD
Thammasat University Faculty of Medicine
64 participants (actual enrollment reported by the registry).
First Submitted
January 12, 2024
First Posted
January 25, 2024
Study Start
March 1, 2023
Actual (reported)The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD
Contact the study team to confirm eligibility.
Primary Completion
January 31, 2024
Actual (reported)Study Completion
May 31, 2024
Actual (reported)Last Updated
January 17, 2025
Record last verified: 2025-01
Individual participant data (IPD) and documents will be available for sharing immediately after publication for a period of 2 years.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: